8th Annual Advances in Colorectal Oncology: Evolving Trends in Evidence-Based Practice — On Demand

Tuesday, November 26, 2024, 8:00 AM - Saturday, August 30, 2025, 11:00 PM

Originally held live on November 7—8, 2024, this annual symposium focuses on the surgical and multidisciplinary management of colorectal cancer, featuring national and international leaders in Surgery, Medical Oncology, and Radiation Oncology. Highlights from the 2024 program include:

— Live surgical presentations streamed directly from MSK's operating rooms, featuring cutting-edge techniques and discussions on robotic right and left colectomy and robotic proctectomy.
— A keynote address from Dr. Emmanouil Fokas, who delivered the prestigious Stuart H.Q. Quan Lecture, offering a forward-looking perspective on the future of radiation therapy for rectal cancer.
— Updates on recent clinical trials, including ACO/ARO/AIO-21, OCHESTRA, and the Phase III RELARC trial.
— Presentations on critical updates in surgical decision-making, controversies in nonoperative management of locally advanced rectal cancer, and the latest advancements in the treatments for metastatic colorectal cancer.  

For more information about this on-demand program, including a detailed list of presentations, view the brochure from the live symposium. Please be advised that the following sessions and lectures from the live program will not be available on demand: the Tumor Boards, the Non-Accredited Industry Session, and the lecture titled "Surgery for Non-responders: Is TME the Standard?".

This program is tailored for medical oncologists, radiation oncologists, interventional radiologists, colorectal/hepatopancreatobiliary/oncologic surgeons, gastroenterologists, pathologists, and other oncology care team members dedicated to improving rectal cancer care.

1. Describe the requirements for a successful multidisciplinary colorectal cancer program
2. Explain recent updates and clinical trials in colorectal cancer
3. Identify appropriate candidates for "Watch and Wait"
4. Discuss evidence-based practice recommendations for the management of hereditary and colitis-associated cancers
5. Review evidence-based practices in the management of Low-grade mucinous neoplasms (LAMN)

Access to the course content requires registration. Once registered, all materials, including relevant financial disclosures and instructions for claiming credit, are located under the 'Course Content' tab. This on-demand program is available for purchase until May 31, 2025. For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through August 31, 2025.

On Demand Access Fees
— Physicians (MDs, DOs, and PhDs): $400
— Advanced Practice Providers: $350
— Residents, Fellows, and Other Healthcare Providers: $300
— MSK Employees: Complimentary

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information and to submit a request. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

— 12.50 Medical Knowledge MOC Points in the American Board of Internal Medicine's Maintenance (ABIM) of Certification Assessment Recognition program; and
— 12.50 Accredited CME and Self-Assessment MOC points in the American Board of Surgery’s (ABS) Continuous Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABS MOC credit.

Recorded/Review Date: November 7-8, 2024 | Original Release Date: November 26, 2024 | Termination Date: August 31, 2025

 

Julio Garcia-Aguilar, MD, PhD
Chief, Colorectal Service, 
Department of Surgery;
Benno C. Schmidt Chair in Surgical Oncology;
Director, Colorectal Cancer Research Center
Memorial Sloan Kettering Cancer Center;
Professor of Surgery, Weill Cornell Medical College

Andrea Cercek, MD
Section Head, Colorectal Cancer;
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers;
Associate Attending, Gastrointestinal Oncology Service,
Department of Medicine

Garrett M. Nash, MD, MPH 
Vice Chair for Quality and Safety;
Associate Attending, Colorectal Service,
Department of Surgery

Paul Romesser, MD
Director of Colorectal and Anal Cancer,
Department of Radiation Oncology

Maria Widmar, MD, MPH
Assistant Attending, Colorectal Service,
Department of Surgery  

Rona Yaeger, MD
Associate Attending, Gastrointestinal Oncology Service,
Department of Medicine 

 

MSK Symposium Planners

Philip S. Bauer, MD MS
Colorectal Surgery Fellow

Rachel Rassam, NP
Adult Care Nurse Practitioner 

 

Invited Symposium Faculty

René Adam, MD, PhD
Professor, Department of Surgery
Hôpital Paul-Brousse Ap-Hp
Villejuif, France

Geerard Beets, MD
Professor, Department of Surgery
The Netherlands Cancer Institute
Amsterdam, The Netherlands

Emmanouil Fokas, MD, DPhil
Professor and Chairman
Department of Radiation Oncology, Cyberknife and Radiotherapy
University Hospital Cologne
Cologne, Germany 

Tsuyoshi Konishi, MD, PhD
Associate Professor
Department of Colon and Rectal Surgery
MD Anderson Cancer Center
Houston, TX, USA

Danilo Miskovic, MD, PhD
Consultant Colorectal Surgeon
St. Marks Hospital
Colorectal & Robotic Surgery Centre
HCA Healthcare UK
London, United Kingdom 

Aparna Parikh, MD
Associate Professor; Director; Medical Director
Harvard Medical School
Global Cancer Care Program
Young Adult Colorectal Cancer Center
Massachusetts General Hospital
Boston, MA

Rodrigo Oliva Perez, MD, PhD
Associate Physician, Division of Colon and Rectal Surgery
Department of Gastroenterology 
Hospital Alemão Oswaldo Cruz
Sao Paulo, Brazil

Arthur Sun Myint, FRCP (Ed), DMRT, FRCS, FRCR, FICS
Lead Clinician (Papillon); Consultant in Clinical Oncology; Honorary Clinical Professor
University of Liverpool
Liverpool, United Kingdom 

C. Kees Verhoef, MD, PhD
Head of the Department Surgical Oncology and GastroIntestinal Surgery
Erasmus MC Cancer Institute
Rotterdam, The Netherlands

Yi Xiao, MD
Professor, Department of Surgery 
Peking Union Medical College Hospital
Beijing, China

 

MSK Symposium Faculty 

Mohammad Abbass, MD
Assistant Attending, Colorectal Service,
Department of Surgery

Louise Connell, MB BCh BAO, BMedSc
Assistant Attending, Gastrointestinal Oncology Service,
Department of Medicine

Christopher Crane, MD
Head, HPB Section;
Attending, Department of Radiation Oncology

Luis Diaz Jr., MD
Division Head, Solid Tumor Oncology;
Grayer Family Chair; 
Attending, Gastrointestinal Oncology Service,
Department of Medicine

Imane El Dika, MD
Assistant Attending, Gastrointestinal Oncology Service,
Department of Medicine 

Michael Foote, MD
Assistant Attending, Gastrointestinal Oncology Service,
Department of Medicine 

Marc J. Gollub, MD, FACR
Attending, Body Imaging Service, 
Department of Radiology;
Director, Colorectal Radiology;
Professor of Radiology, Weill Cornell Medical College

Georgios Karagkounis, MD
Assistant Attending, Colorectal Service,
Department of Surgery 

Conrad Moher, MD
Pathology Fellow

Emmanouil P. Pappou, MD, PhD
Assistant Attending, Colorectal Service, 
Department of Surgery 

Marsha Reyngold, MD, PhD
Assistant Attending,
Department of Radiation Oncology 

Leonard Saltz, MD
Head, Colorectal Oncology Section; 
Attending, Gastrointestinal Oncology Service, 
Department of Medicine 

Neil H. Segal, MD, PhD
Research Director, Division of Gastrointestinal Oncology; 
Associate Attending, Gastrointestinal Oncology Service, 
Department of Medicine 

Jinru Shia, MD
Attending, 
Department of Pathology and Laboratory Medicine; 
Director, Gastrointestinal Pathology;
Professor of Pathology, Weill Cornell Medical College

J. Joshua Smith, MD, PhD
Associate Member; Associate Attending, Colorectal Service, 
Department of Surgery;
Associate Professor, Weill Cornell Medical College

Vlasios S. Sotirchos, MD
Assistant Attending, Interventional Radiology Service,
Department of Radiology

Alice Wei, MD, CM, MSc, FRCSC, FACS
Co-Director, Surgical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research;  
Attending, Hepatopancreatobiliary Service,
Department of Surgery;
Associate Professor of Surgery, Weill Cornell Medical College

Iris H. Wei, MD 
Assistant Attending, Colorectal Service, 
Department of Surgery 

Martin R. Weiser, MD
Stuart H.Q. Quan Chair in Colorectal Surgery;
Attending, Colorectal Service, 
Department of Surgery;
Professor of Surgery, Weill Cornell Medical College

Vonetta M. Williams, MD, PhD
Assistant Attending, 
Department of Radiation Oncology 

 

View relevant financial relationships as of the program dates, November 7—8, 2024. 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.